Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [Elsevier BV]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李健的小迷弟的应助被陈皮采纳,获得20
刚刚
小米的应助被英俊的如柏采纳,获得10
刚刚
hhhh完成签到,获得积分20
刚刚
1秒前
daker发布了新的文献求助10
1秒前
V0x6完成签到,获得积分10
1秒前
2秒前
YYJ发布了新的文献求助10
2秒前
2秒前
perper发布了新的文献求助10
2秒前
ngz完成签到,获得积分10
3秒前
天天开心发布了新的文献求助10
3秒前
CpStars发布了新的文献求助10
3秒前
123完成签到,获得积分10
3秒前
wangdave发布了新的文献求助10
3秒前
chen不爱工作完成签到 ,获得积分10
4秒前
hyx发布了新的文献求助10
4秒前
OrangeMoon发布了新的文献求助10
4秒前
无奈太兰的应助被Y星人采纳,获得10
4秒前
4秒前
烂漫的淇发布了新的文献求助10
4秒前
Clarissa发布了新的文献求助10
5秒前
5秒前
橘子皮完成签到 ,获得积分10
5秒前
daker发布了新的文献求助30
5秒前
852的应助被董大米采纳,获得10
6秒前
谢雷XIELei的应助被邢慧兰采纳,获得10
6秒前
6秒前
李shuashua发布了新的文献求助10
6秒前
7秒前
乐叻完成签到,获得积分10
7秒前
7秒前
wujiaman345完成签到,获得积分10
7秒前
汤汤完成签到,获得积分10
7秒前
enzyme完成签到,获得积分10
7秒前
平淡的莆完成签到,获得积分10
8秒前
在水一方的应助被鲁世键采纳,获得10
8秒前
美丽的小羊完成签到,获得积分10
9秒前
飘逸的老头完成签到,获得积分10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aspects of Post-SPE Phonology 2000
Recombinant human Type III collagen with native-like assembly and real biomaterial performance 1000
Children in Mind: Their mental health in today’s world and what we can do to help them 900
Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals 888
Rosenblum, Global Change Biology 800
Holistic Discourse Analysis, Second Edition by Robert E. Longacre (2012-09-10) 666
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 物理 有机化学 化学工程 内科学 生物化学 复合材料 催化作用 心理学 细胞生物学 无机化学 电极 光电子学 人工智能
热门帖子
关注 科研通微信公众号,转发送积分 7875350
求助须知:如何正确求助?哪些是违规求助? 9391045
关于积分的说明 20785011
捐赠科研通 7477141
什么是DOI,文献DOI怎么找? 3352527
关于科研通互助平台的介绍 2492995
邀请新用户注册赠送积分活动 2379326